Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin for Cognitive Progression in Huntington's Disease
2024-518875-73-00Phase 3Completed
- Sponsor
- Health Research Institute Hospital La Fe
- Start
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Huntington disease (HD) comparing Metformin arm with Placebo arm (2 arms). Primary endpoint: UHDRS cognitive score. Started Dec 2024; status: completed.
02
Drugs
metformin
03
Conditions
Huntington disease (HD)
Beyond the preview
Go deeper on 2024-518875-73-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-518875-73-00.